None
Quote | PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS)
Last: | $0.0701 |
---|---|
Change Percent: | 15.05% |
Open: | $0.0807 |
Close: | $0.0701 |
High: | $0.092 |
Low: | $0.0665 |
Volume: | 8,640,505 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS)
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers on Tuesday! We’ve got a bankruptcy filing, earnings reports, a reverse stock split, ...
PhaseBio Pharmaceuticals ( NASDAQ: PHAS ), a biotech focused on cardiovascular diseases, dropped ~9% pre-market Monday after the company announced plans for Chapter 11 bankruptcy and a non-binding agreement to sell its leading program, bentracimab. The voluntary petiti...
Message Board Posts | PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
PhaseBio Pharmaceuticals Inc. Company Name:
PHAS Stock Symbol:
NASDAQ Market:
Bidding Process and Auction Projected to Conclude December 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today announced that...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today reported financial results for the second quarter ended June 30, 2022, and provided an upd...